4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 25c
Tweet
Share
E-mailGet Alerts FDMT Hot Sheet
Join SI Premium – FREE
4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) reported Q2 EPS of ($0.98), $0.25 worse than the analyst estimate of ($0.73).
For earnings history and earnings-related data on 4D Molecular Therapeutics, Inc. (FDMT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Momo (MOMO) Tops Q2 EPS by 8c; offers guidance
- Jefferies Starts Uranium Energy Corp (UEC) at Hold
- Jefferies Starts Centrus Energy Corp. (LEU) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
